CD4 and colitis: Here, in an effort to further explore the role of 5-HT7 in the pathogenesis of colitis, we conducted a series of studies investigating the impact of the novel 5-HT7 receptor antagonists, MC-170073 and MC-230078, in both the DSS and CD4+ T-cell transfer models of colitis (14).